Abstract
The perinatal prognosis for drug-addicted pregnant women and their children is clearly improved by a specialized treatment of their addiction, of which an essential element is the prescription of a substitute along with the necessary medico-and psychosocial support, and by early supervision of the pregnancy (1–3). Even though the prescription of high doses of buprenorphine is, in principle, not approved in France during pregnancy, the small number of openings available in methadone centers and more liberal prescription rules for high-dose buprenorphine mean, in practice, that numerous pregnant, drug-addicted women are having their treatment substituted with high-dose buprenorphine.
This is a preview of subscription content, log in via an institution to check access.
Access this chapter
Tax calculation will be finalised at checkout
Purchases are for personal use only
Preview
Unable to display preview. Download preview PDF.
References
Kandall SR, Doberczak TM, Jantunen M, Stein J. The methadone-maintained pregnancy. Clin Perinatol 1999; 26: 173–83.
Lejeune C, Floch-Tudal C, Montamat S, et al. Prise en charge des femmes enceintes toxicomanes et de leurs enfants. Arch Pédiatr 1997; 4: 263–70.
Randal T. Intensive prenatal care may deliver healthy babies to pregnant drug abusers. JAMA 1991; 265: 2773–4.
Jernite M, Viville B, Escande B, et al. Grossesse et buprénorphine. A propos de 24 cas. Arch Pédiatr 1999; 6: 1179–85.
Fisher G, Etzersdorfer P, Eder H, et al. Buprenorphine maintenance in pregnant opiate addicts. Eur Addict Res 1998; 4 (Suppl.): 32–6.
Fisher G, Johnson RE, Eder H, et al. Treatment of opioid-dependant pregnant women with buprenorphine. Addiction 2000; 2: 239–44.
Mazurier E, Sarda P, Boulot P. Traitement par Buprénorphine (Temgésic®) de la dépendance aux opiacés chez la femme enceinte. In: 26è Journées Nationales de la Société Française de Médecine Périnatale, livre des communications, Brest 1996.
Kandall SR. Treatment strategies for drug-exposed neonates. Clin Perinatol 1999; 26: 231–43.
Lipsitz PT. A proposed narcotic withdrawal score for use with newborn infants: a pragmatic evaluation of its efficacy. Clin Pediatr 1975; 14: 592–4.
Committee on Drugs. American Academy of Pediatrics. BERLIN CM, MacCarver DG, Notterman DA, et al. Neonatal drug withdrawal. Pediatrics 1998; 101: 1079–88.
Lejeune C, Ropert JC, Montamat S, et al. Devenir médico-social de 59 nouveau-nés de mère toxicomane. J Gynecol Obstet Biol Reprod 1997; 26: 395: 404.
Robins LM, Mills JL. Effect of in utero exposure to street drugs. Am J Public Health 1993;83(Suppl.): l-32.
Regan DO, Ehrlich SM, Finnegan LP. Infant of drug addicts: at risk for child abuse, neglect, and placement in foster care. Neurotoxicol Teratol 1987; 9: 315–9.
Davis SK. Chemical dependency in women: a description of its effects and outcome on adequate parenting. J Subst Abuse Treat 1990; 7: 225–32.
Bays J. Substance abuse and child abuse: impact of addiction on the child. Pediatr Clin North Am 1990; 37: 881–904.
Tracqui A, Kintz P, Ludes B. Buprenorphine-related deaths among drug addicts in France: a report on 20 fatalities. J Anal Toxicol 1998; 22: 430–4.
Harrison L. The validity of self-reported drug use in survey research: an overview and critique of research methods. NIDA Res Monogr 1997; 167: 17–36.
Editor information
Editors and Affiliations
Rights and permissions
Copyright information
© 2002 Humana Press Inc., Totowa, NJ
About this chapter
Cite this chapter
Lejeune, C., Aubisson, S., Simmat-Durand, L., Cneude, F., Piquet, M. (2002). Buprenorphine and Pregnancy. In: Kintz, P., Marquet, P. (eds) Buprenorphine Therapy of Opiate Addiction. Forensic Science and Medicine. Humana Press, Totowa, NJ. https://doi.org/10.1007/978-1-59259-282-1_11
Download citation
DOI: https://doi.org/10.1007/978-1-59259-282-1_11
Publisher Name: Humana Press, Totowa, NJ
Print ISBN: 978-1-4684-9713-7
Online ISBN: 978-1-59259-282-1
eBook Packages: Springer Book Archive